Wren, Barry G <br/><br/>
Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women.  [electronic resource] 

 -  Menopause (New York, N.Y.)   
 - 13-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1072-3714 
<br/><br/><label>Standard No.: </label>10.1097/00042192-200310010-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Affect<br/>Aged<br/>Apolipoproteins A--blood<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Collagen--blood<br/>Collagen Type I<br/>Double-Blind Method<br/>Female<br/>Hot Flashes--drug therapy<br/>Humans<br/>Lipids--blood<br/>Middle Aged<br/>Osteocalcin--blood<br/>Peptides--blood<br/>Postmenopause<br/>Progesterone--administration & dosage<br/>Quality of Life<br/>Severity of Illness Index<br/>Surveys and Questionnaires<br/>Treatment Outcome<br/>Triglycerides--blood